International Journal of Environmental Research and Public Health · 7 authors, 6 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This qualitative study used a focus group with 5 breast cancer survivors to evaluate the usability and content preferences of the Xemio mHealth app, finding that side effect tracking and reliable information were valued, but ease of use was a concern, especially for older participants. The main limitation is the very small sample size from a single focus group, which limits generalizability.
Breast cancer survivorship is increasing, highlighting the need for tools to support long-term quality of life and self-management. mHealth apps like Xemio aim to provide patient-reported outcomes, reliable information, and communication with healthcare providers. Methods: A qualitative focus group study was conducted with 5 breast cancer survivors (aged 52-71) at Hospital Clínic de Barcelona. The study involved two sessions: a semi-structured discussion on information needs and a cognitive walkthrough test of the Xemio app prototype. Data were collected via audio recordings, notes, and questionnaires. Key Results: Participants valued the app's ability to track side effects and provide reliable content. However, they expressed concerns about ease of use and navigation, with older participants and those less familiar with smartphones experiencing more difficulty. Participants generally trusted hospital-provided information but were wary of internet sources. They expressed interest in practical news and social activities. Limitations: The study had a very small sample size (n=5) from a single focus group, which may not capture diverse perspectives. The presence of an oncologist in the first session could have influenced participant responses. Recruitment was challenging due to COVID-19 restrictions. Implications: The findings suggest that mHealth tools for breast cancer patients must prioritize accessibility and user-centered design, particularly for older adults. While patients perceived benefits, the study highlights the need for iterative design and further research, such as the planned randomized pilot, to assess long-term impact on quality of life.
